Seborrheic Dermatitis (Dandruff) Treatment
Covered by Aetna in California

Ketoconazole 2% shampoo twice weekly × 4 weeks (induction) then once weekly as maintenance; for facial or body seborrheic dermatitis, ketoconazole 2% cream applied to affected areas twice daily × 4 weeks; desonide 0.05% cream applied to inflamed facial areas once or twice daily as needed (not long-term) to reduce erythema and itch

Ciclopirox 1% shampoo (Loprox) once daily × 4 weeks for ketoconazole-resistant or ketoconazole-intolerant scalp disease; selenium sulfide 2.5% shampoo (prescription strength — OTC versions are 1%) twice weekly; zinc pyrithione 2% bar or shampoo (OTC) as maintenance; for refractory facial seborrheic dermatitis, roflumilast 0.3% foam (Zoryve) once daily — FDA-approved since 2022, well-tolerated without steroid side effects; tacrolimus 0.1% ointment for recurrent facial seborrheic dermatitis where steroid avoidance is preferred; oral itraconazole 200 mg daily × 1 week/month for severe or uncontrolled scalp involvement

Yes (generic antifungals) — generic ketoconazole 2% shampoo typically $15–$40 for 120 mL; generic ciclopirox shampoo typically $20–$50. Roflumilast foam (branded): likely subject to step therapy on Aetna CA — prior generic antifungal trial required; with insurance Tier 3–4 placement may involve $50–$100+ copay. Low-potency topical steroids (desonide) are Tier 1 generic at $5–$20.

Seborrheic dermatitis is caused by a dysregulated immune response to Malassezia yeast species, which are part of normal skin flora but overgrow in sebaceous areas. Antifungal agents reduce Malassezia burden; topical corticosteroids address inflammation. The AAD emphasizes that treatment controls rather than cures seborrheic dermatitis — maintenance therapy with medicated shampoos or intermittent antifungal application is required for most patients. For scalp-only disease, prescription-strength ketoconazole 2% shampoo is the evidence-based first-line agent (superior to 1% OTC formulation). Roflumilast foam represents a newer non-steroidal option with strong Phase III evidence for facial and scalp seborrheic dermatitis in patients ≥9 years.

OTC shampoos contain 1% ketoconazole, 1% selenium sulfide, or 1% zinc pyrithione — effective for mild dandruff but often insufficient for moderate-to-severe seborrheic dermatitis. Prescription ketoconazole 2% shampoo provides double the antifungal concentration and has stronger evidence for scalp seborrheic dermatitis. It is a covered formulary generic on Aetna CA, typically at $15–$40 for a 120 mL bottle used twice weekly. Prescription ciclopirox shampoo is a covered alternative. If your scalp also has significant inflammation with redness and itch, adding a brief course of low-potency topical steroid (desonide or hydrocortisone) is appropriate while the antifungal takes effect.

Roflumilast foam (Zoryve) is FDA-approved for seborrheic dermatitis and is on the Aetna 2026 Drug Guide, but as a branded product it is subject to step therapy on most Aetna CA plans — meaning you'll likely need to document a trial of prescription ketoconazole or ciclopirox first before Aetna will authorize it. The clinical advantage of roflumilast foam is that it avoids the skin atrophy risk of topical steroids while addressing both the inflammatory and scaly components of facial seborrheic dermatitis. Dr. Bhavsar will prescribe the appropriate first-line option and document any treatment failures to support a roflumilast PA if needed.

Yes — seborrheic dermatitis typically flares in winter months even in California, particularly in inland areas where humidity drops significantly. Cold, dry air and indoor heating reduce ambient humidity, which weakens the skin barrier and allows Malassezia overgrowth. Stress (a known flare trigger) often peaks in winter for many patients. Year-round maintenance with a medicated shampoo (even once weekly once controlled) significantly reduces winter flares compared to treating only during active flare-ups.

Yes. Aetna commercial plans cover telehealth visits for Seborrheic Dermatitis (Dandruff) in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your dandruff treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your dandruff treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.